ISHIB, and Scientific Co-Chairs Ileana Pina, MD, MPH, Keith C. Ferdinand, MD, and Neal Schneiderman, PhD, invite you to participate in this annual CME activity. The scientific program will feature plenary sessions, workshops, symposia, and abstracts of new research on cardiovascular disease and other issues of importance to ethnic minority health. Presentations will include findings from the most recent clinical trials, proven approaches for cardiovascular disease treatment and prevention and sessions emphasizing behavioral techniques to help patients modify behaviors that affect health.
ISHIB2012 CONFERENCE CO-CHAIRS
Ileana Pina, MD, MPH
Albert Einstein College of Medicine
Keith C. Ferdinad, MD
Tulane University School of Medicine
Neal Schneiderman, PhD
University of Miami Miller School of Medicine
Plenary sessions will explore cardiovascular risk factors and their individual and collective impact on the health of ethnic minority populations. Sessions will be conducted in lecture and panel formats where presenters will address ethnic differences, analyze recent clinical trial data, and discuss the theme, "Gender Disparities in Cardiovascular Disease (CVD) in Underserved Populations.”
Workshops will cover all topics presented in plenary sessions with more in depth information in an interactive, peer-directed, topic-specific format.
Supported symposia will address a variety of topics in 90- to 120-minute meal sessions featuring panel and lecture formats.
At the completion of 2012 programming, participants should be able:
1. To understand the issues related to gender disparities in underserved populations on outcomes in CV Disease
2. To review the social, environmental, racial and ethnic determinants of Women’s CV Health
3. To understand the opportunities and barriers for women related to inclusion in clinical trials
Typical attendees include healthcare providers and advocates concerned with the quality of care and treatment of ethnic patients.
- Medical Researchers
- Public Health Professionals
- Medical Students
- Physician Assistants
- Social Workers
- Pharmaceutical Researchers and Professionals
- Federal and State Health Professionals
- Dietitians and Nutritionists
CONFERENCE PROMOTION PACKET
Tell your colleagues about ISHIB2012. The Promotion Packet Includes Conference Facts, Program-at-a-Glance, media news advisory, registration forms, and ads of various sizes for use in your newspapers, magazines, or newsletters.
Please consider sending the information packet to your colleagues as well as sending the ISHIB2012 ads to those in your public affairs office who develop your organization's communication pieces.
Click here to download CONFERENCE PROMOTION PACKET
ISHIB2012 has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Society of Hypertension, Inc. and ISHIB. The American Society of Hypertension, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
The American Society of Hypertension, Inc. (ASH) designates this educational activity for a maximum of 10.5 hours AMA Physician's Recognition Award in category 1 credit(s). Physicians should claim only credit commensurate with the extent of their participation in the activity.
CE CREDITS FOR NURSES, DIETITIANS, AND OTHER HEALTHCARE PROFESSIONALS
ISHIB has been reviewed and approved as an authorized provider by the International Association for Continuing Education and Training (IACET) and uses the criteria and guidelines designated by that organization as the basis for granting continuing education units (CEUs). Participants who successfully complete this activity can receive up to 1.05 CEUs.
CE CREDITS FOR PHARMACISTS
will be provided by the National Pharmaceutical Association.
ASH, Inc. strives to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All presenters in such activities are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the session in which they are participating. This pertains to relationships, in place at the time of the activity or in the twelve (12) months preceding the activity, with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. Speakers are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.